Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
暂无分享,去创建一个
Brian A. King | Christopher M. Jones | P. Briss | B. Xia | P. Shields | J. Pirkle | J. Layden | B. Blount | L. Valentín-Blasini | Maria Morel-Espinosa | Min-Ae Song | Z. Kuklenyik | J. Barr | G. Baldwin | C. Sosnoff | Lanqing Wang | M. Wewers | D. Rose | L. Delaney | V. D. De Jesús | D. Meaney-Delman | Anita Patel | J. Rees | I. Ghinai | C. Spitzer | D. Chambers | C. Reese | M. Karwowski | Michael S. Gardner | Kevin T. Caron | V. Krishnasamy | D. Heitkemper | Jerry Thomas | Cory Holder | Martha Braselton | P. Espinosa | Joseph Corstvet | Tiffany H. Seyler | Christina Brosius | Elizabeth A. Cowan | Lalith K. Silva | Cody A. Newman | Carolina Fernandez | Gregory B. Reis | Jennifer D Kusovschi | D. Tevis | C. Watson | Michael Gardner | Tiffany H Seyler | Jennifer D. Kusovschi | Vikram Krishnasamy | Isaac Ghinai | Kevin T Caron | Michael S Gardner
[1] A. Cardona,et al. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers , 2020, Clinical and Translational Oncology.
[2] Daniel Temas,et al. E-Cigarette- and Vaping-Related Lung Injury (EVALI) at a Regional Hospital System in South Carolina , 2020, Case reports in pulmonology.
[3] Benjamin M. Smith,et al. Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health , 2020, International journal of molecular sciences.
[4] M. Goddard,et al. Severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation support: a consequence of vaping , 2020, ERJ Open Research.
[5] T. Welte,et al. Three Patients With Acute Pulmonary Damage Following the Use of E-Cigarettes-A Case Series. , 2020, Deutsches Arzteblatt international.
[6] D. O’Shea,et al. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate , 2019, Proceedings of the National Academy of Sciences.
[7] R. Beger,et al. Evaluation of the Performance of Lipidyzer Platform and its Application in the Lipidomics Analysis in Mouse Heart and Liver. , 2020, Journal of proteome research.
[8] J. Freudenheim,et al. Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[9] Brian A. King,et al. Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, December 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[10] R. Lynfield,et al. Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement — Minnesota, 2018 and 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[11] Brian A. King,et al. Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[12] Brian A. King,et al. Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[13] Brian A. King,et al. Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[14] K. Swanson,et al. Pathology of Vaping-Associated Lung Injury. , 2019, The New England journal of medicine.
[15] J. Freudenheim,et al. Electronic versus Combustible Cigarette Effects on Inflammasome Component Release into Human Lung , 2019, American journal of respiratory and critical care medicine.
[16] R. Pacifici,et al. Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease , 2018, Clinical chemistry and laboratory medicine.
[17] Constantine A Raptis,et al. Imaging Findings of Vaping-Associated Lung Injury. , 2019, AJR. American journal of roentgenology.
[18] E. Reboul. Vitamin E Bioavailability: Mechanisms of Intestinal Absorption in the Spotlight , 2017, Antioxidants.
[19] Jiri Mlcek,et al. Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids , 2015, International journal of molecular sciences.
[20] V. Rosilio,et al. The distribution and relative hydrolysis of tocopheryl acetate in the different matrices coexisting in the lumen of the small intestine during digestion could explain its low bioavailability. , 2013, Molecular nutrition & food research.
[21] V. A. Raghunathan,et al. Modulated phases of phospholipid bilayers induced by tocopherols. , 2012, Biochimica et biophysica acta.
[22] C. Casals,et al. Role of lipid ordered/disordered phase coexistence in pulmonary surfactant function. , 2012, Biochimica et biophysica acta.
[23] A. Neumann,et al. Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation. , 2008, Biochimica et biophysica acta.
[24] B. Blount,et al. Picogram measurement of volatile n-alkanes (n-hexane through n-dodecane) in blood using solid-phase microextraction to assess nonoccupational petroleum-based fuel exposure. , 2008, Analytical chemistry.
[25] J. B. Massey,et al. Interaction of vitamin E with saturated phospholipid bilayers. , 1982, Biochemical and biophysical research communications.
[26] J. K. Taylor. Quality Assurance of Chemical Measurements , 1984 .